Gene · 5892
Papers2,681
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,681
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. | United European Gastroenterol J | 2026 | 41691430 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group. | Asian Pac J Cancer Prev | 2026 | 41660923 | PubTator, text mining | PubMed |
| [Homologous recombination repair gene variants in hormone-sensitive prostate cancer]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41644423 | PubTator, text mining | PubMed |
| Hereditary ovarian cancer in women with African ancestry: a scoping review. | Fam Cancer | 2026 | 41619087 | PubTator, text mining | PubMed |
| Results of a multigene panel testing approach targeting patients with suspected genetic predisposition to pancreatic ductal adenocarcinoma. | Eur J Hum Genet | 2026 | 41611968 | PubTator, text mining | PubMed |
Hereditary Risk Assessment of Cancer Using Clinical History in Patients Diagnosed with Breast or Ovarian Cancer Receiving Treatment at Tertiary Care Hospital in Western Rajasthan - A Cross-sectional Study. | Ann Afr Med | 2026 | 41568657 | PubTator, text mining | PubMed |
| High-throughput mapping of 6,888 RAD51D variants identifies distinct biochemical functions needed for homologous recombination and olaparib response. | bioRxiv | 2026 | 41542474 | PubTator, text mining | PubMed |
| Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databases. | Breast Cancer Res | 2026 | 41530809 | PubTator, text mining | PubMed |
| Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications. | Arch Gynecol Obstet | 2026 | 41528496 | PubTator, text mining | PubMed |
| Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach. | Gynecol Oncol | 2026 | 41520566 | PubTator, text mining | PubMed |
| Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands. | Breast | 2026 | 41274190 | PubTator, text mining | PubMed |
| Cryo-electron microscopic visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2. | Science | 2026 | 41196948 | PubTator, text mining | PubMed |
| Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution. | Am J Obstet Gynecol | 2026 | 41183726 | PubTator, text mining | PubMed |
| Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor/normal paired comprehensive genomic profiling test, in Japan. | J Hum Genet | 2026 | 40926019 | PubTator, text mining | PubMed |
| Serous tubal intraepithelial carcinoma-looking into the earliest events of ovarian cancer development. | Acad Oncol | 2025 | 41878142 | PubTator, text mining | PubMed |
| PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function. | Cancer Cell Int | 2025 | 41419868 | PubTator, text mining | PubMed |
| Pathogenic variants in affected and unaffected individuals from Indonesian familial cancer: a multigene panel analysis. | Sci Rep | 2025 | 41407742 | PubTator, text mining | PubMed |
| A network-based discovery of prognostic markers in recurrent IDH wild-type gliomas. | Front Genet | 2025 | 41356219 | PubTator, text mining | PubMed |
| Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. | J Med Genet | 2025 | 41159931 | PubTator, text mining | PubMed |
| Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2025 | 41070818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5892/papers?page=4